RAPH OTC
Raphael Pharmaceutical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +536.4%
3Y: +35.9%
$1.40
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$0
+0.0% ▲
Gross Profit
$0
+0.0% ▲
Operating Income
-$2M
-13.3% ▼
Net Income
-$2M
-13.0% ▼
EPS (Diluted)
$-0.08
-1.1% ▼
EBITDA
-$2M
-13.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| Gross Margin | — | — | — | — |
| R&D Expenses | $776K | $1M | $569K | $776K |
| SG&A Expenses | $853K | $2M | $763K | $733K |
| Operating Expenses | $2M | $3M | $1M | $2M |
| Operating Income | -$2M | -$3M | -$1M | -$2M |
| Operating Margin | — | — | — | — |
| Interest Expense | $0 | $3K | $3K | $2K |
| Income Before Tax | -$2M | -$3M | -$1M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2M | -$3M | -$1M | -$2M |
| Net Margin | — | — | — | — |
| EPS (Diluted) | $-0.10 | $-0.23 | $-0.08 | $-0.08 |
| EBITDA | -$2M | -$3M | -$1M | -$2M |
| Shares Outstanding | 15M | 14M | 17M | 19M |